{"transactions":[{"id":838253,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Regulatory Affairs"}}],"security":"Common Stock","published_at":"2026-03-17T21:44:21.000Z","date":"2026-02-17","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":1.27,"value":1270.0,"ownership":{"direct":true},"balance_after":1012,"source":{"system":"sec-edgar","filing":"0001493152-26-010630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000149315226010630/ownership.xml","form_type":"4"}},{"id":947021,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Regulatory Affairs"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T01:00:10.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date."}],"balance_after":9000,"derivative":{"exercise_price":2.18,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001493152-26-000704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000149315226000704/ownership.xml","form_type":"4"}},{"id":1303564,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"officer":true,"officer_title":"SVP, Regulatory Affairs"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-14T23:56:51.000Z","date":"2025-01-13","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date."}],"balance_after":8000,"derivative":{"exercise_price":1.38,"expiration_date":"2035-01-12","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001654954-25-000411","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000165495425000411/section16.xml","form_type":"4"}},{"id":1685677,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"officer":true,"officer_title":"SVP, Regulatory Affairs"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-06T02:00:31.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest as to 25% upon the 12-month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12-month anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":0.6099,"expiration_date":"2034-01-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001654954-24-000290","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000165495424000290/section16.xml","form_type":"4"}},{"id":2063041,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"officer":true,"officer_title":"SVP, Regulatory Affairs"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T21:06:33.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the\n12 month anniversary of the grant date."}],"balance_after":50000,"derivative":{"exercise_price":0.31,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001654954-23-000148","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000165495423000148/section16.xml","form_type":"4"}},{"id":2444437,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T23:59:53.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 40% upon the 12 month anniversary of the grant date, and will vest as to 60% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date"}],"balance_after":15000,"derivative":{"exercise_price":1.88,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000905718-22-000038","document":"dermata_fm4jan32022.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571822000038/dermata_fm4jan32022.xml","form_type":"4"}},{"id":2600584,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Warrant to Purchase Common Stock","published_at":"2021-08-17T16:51:09.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":4878,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Munera Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":4878,"derivative":{"exercise_price":20.5,"exercise_date":"2016-11-15","expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":4878},"source":{"system":"sec-edgar","filing":"0000905718-21-001112","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001112/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600583,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Series 1a Warrants","published_at":"2021-08-17T16:51:09.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Munera Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_date":"2016-11-15","expiration_date":"2026-03-14","underlying":"Common Stock","underlying_shares":4878},"source":{"system":"sec-edgar","filing":"0000905718-21-001112","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001112/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600582,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Series 1 Preferred Stock","published_at":"2021-08-17T16:51:09.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Munera Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13658},"source":{"system":"sec-edgar","filing":"0000905718-21-001112","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001112/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600581,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Series 1c Preferred Stock","published_at":"2021-08-17T16:51:09.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":357142,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Munera Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17421},"source":{"system":"sec-edgar","filing":"0000905718-21-001112","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001112/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600580,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Series 1b Preferred Stock","published_at":"2021-08-17T16:51:09.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Munera Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4878},"source":{"system":"sec-edgar","filing":"0000905718-21-001112","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001112/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600579,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Series 1a Preferred Stock","published_at":"2021-08-17T16:51:09.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Munera Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":19512},"source":{"system":"sec-edgar","filing":"0000905718-21-001112","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001112/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600578,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Series 1d Preferred Stock","published_at":"2021-08-17T16:51:09.000Z","date":"2021-08-17","kind":"exercise","acquired":false,"shares":61821,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Munera Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1d Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1d Preferred Stock was convertible at any time and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1d Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9162},"source":{"system":"sec-edgar","filing":"0000905718-21-001112","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001112/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600577,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-08-17T16:51:09.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":13658,"ownership":{"direct":false,"nature":"By Munera Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":84143,"source":{"system":"sec-edgar","filing":"0000905718-21-001112","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001112/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600576,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-08-17T16:51:09.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":17421,"ownership":{"direct":false,"nature":"By Munera Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":70485,"source":{"system":"sec-edgar","filing":"0000905718-21-001112","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001112/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600575,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-08-17T16:51:09.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":4878,"ownership":{"direct":false,"nature":"By Munera Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":53064,"source":{"system":"sec-edgar","filing":"0000905718-21-001112","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001112/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600574,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-08-17T16:51:09.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":19512,"ownership":{"direct":false,"nature":"By Munera Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":48186,"source":{"system":"sec-edgar","filing":"0000905718-21-001112","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001112/dermata_fm4aug172021.xml","form_type":"4"}},{"id":2600573,"issuer":{"id":8182,"kind":"organization","name":"Dermata Therapeutics, Inc."},"owners":[{"id":60030,"kind":"person","name":"Bedoya-Toro Munera Maria E","position":1,"cik":"0001400048","reported_name":"Bedoya-Toro Munera Maria E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2021-08-17T16:51:09.000Z","date":"2021-08-17","kind":"exercise","acquired":true,"shares":9162,"ownership":{"direct":false,"nature":"By Munera Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the \"IPO\"). The Series 1d Preferred Stock was convertible at any time and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":28674,"source":{"system":"sec-edgar","filing":"0000905718-21-001112","document":"dermata_fm4aug172021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853816/000090571821001112/dermata_fm4aug172021.xml","form_type":"4"}}]}